JF
FLNA

Jump Financial’s Filana Therapeutics FLNA Stock Holding History

Jump Financial’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-91,620
Closed -$181K – 2344
2025
Q4 		$181K Buy
+91,620
New +$293K ﹤0.01% 1766
2025
Q3 		– Sell
-27,351
Closed -$49.5K – 2163
2025
Q2 		$49.5K Buy
+27,351
New +$48.7K ﹤0.01% 1684
2023
Q4 		– Sell
-103,135
Closed -$1.72M – 2186
2023
Q3 		$1.72M Buy
+103,135
New +$2.04M 0.06% 434
2022
Q1 		– Sell
-6,801
Closed -$297K – 1868
2021
Q4 		$297K Sell
6,801
-2,018
-23% -$106K 0.02% 900
2021
Q3 		$547K Buy
+8,819
New +$736K 0.04% 450
2021
Q1 		– Sell
-64,282
Closed -$438K – 1239
2020
Q4 		$438K Sell
64,282
-25,437
-28% -$227K 0.07% 428
2020
Q3 		$1.03M Buy
+89,719
New +$404K 0.21% 112

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Jump Financial's FLNA Position: Q1 2026 in Review

Jump Financial sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 91,620 shares — an estimated $181K sold.

Jump Financial first reported a position in FLNA in Q3 2020 and held it in 7 quarters. The position peaked at $1.72M in Q3 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Jump Financial reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 91,620 Filana Therapeutics shares in Q1 2026, an estimated $181K.
  • Jump Financial first reported a position in Filana Therapeutics in Q3 2020 and held it in 7 quarters.
  • Jump Financial's Filana Therapeutics position peaked at $1.72M in Q3 2023.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.